About Symed
Symed is a Healthcare company based in Hyderabad (India) founded in 1997 by Parthasaradi Reddy and Mohan Rao Dodda, and was acquired by Viyash in November 2021. APIs are manufactured and drug development services are provided. The company has 949 employees. Its Indian entity Symed Labs Limited reported revenue of ₹792 Cr. Symed offers products and services including Active Pharmaceutical Ingredients and Contract Research Services. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Its competitors include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed competitors have raised funding.
Company details
Symed was founded in 1997 in Hyderabad, India, within the pharmaceutical sector. Active pharmaceutical ingredients are produced, alongside drug development services that support formulation and regulatory processes. Operations are centered in India, with a focus on API synthesis and custom development for global clients. Leadership includes co-founders Parthasaradi Reddy and Mohan Rao Dodda, who oversee manufacturing and strategic directions.
- Headquarters Hyderabad, India
- Employees 949
- Founders Parthasaradi Reddy, Mohan Rao Dodda
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website symedlabs.com
- Social LinkedIn Facebook
- Acquired by Viyash (Nov 2021)
- Legal Name Symed Labs Limited
- Date of Incorporation 17 Aug, 1998
- Jurisdiction Hyderabad, Telangana, India
Associated legal entities of Symed
Symed is associated with 4 registered companies on The Company Check; the primary company is Symed Labs Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Symed Labs Limited CIN U24231TG1998PLC029961 | Amalgamated | 17 Aug 1998 | Hyderabad, Telangana | ₹792 Cr | 949 | 7 | View details |
| Sri Shaiva Agrifarm Llp CIN ABB-7653 | Active | 18 Jul 2022 | Hyderabad, Telangana | 3 | View details | ||
| Symed Infratech Llp CIN AAP-4344 | Active | 24 May 2019 | Hyderabad, Telangana | ₹0.2 Cr | 4 | View details | |
| Unkeshwar Estates Llp CIN ABB-2129 | Strike Off | 30 May 2022 | Hyderabad, Telangana | 2 | View details |
Products & Services of Symed
Symed offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients and Contract Research Services.
Production of high-quality APIs for pharmaceutical applications
Provision of chemistry-related solutions for the industry
Investors in Symed
Symed has secured backing from 1 investor. Prominent investors backing the company include Viyash.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
APIs and intermediates are manufactured by Viyash as a CDMO. | 2019 | viyash.com | Hyderabad, India |
Investor details for Symed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Symed Labs Limited (Symed)
Symed Labs Limited is the primary company behind Symed. The boards of the 4 registered companies of Symed currently have 11 directors; the longest-serving is Dodda Vandana, appointed in 2019. 18 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dodda Vandana DIN 09485035 | Designated Partner | 24 May 2019 | 7 yrs 5 mo | Symed Infratech Llp, Sri Shaiva Agrifarm Llp |
| Spandana Dodda DIN 09326607 | Designated Partner | 24 May 2019 | 7 yrs 5 mo | Symed Infratech Llp, Unkeshwar Estates Llp, Sri Shaiva Agrifarm Llp |
| Mohan Rao Dodda DIN 00126836 | Designated Partner | 24 May 2019 | 7 yrs 5 mo | Symed Infratech Llp, Unkeshwar Estates Llp, Sri Shaiva Agrifarm Llp |
| Parthasaradhi Reddy Bandi DIN 00015899 | Designated Partner | 24 Jun 2019 | 7 yrs 4 mo | Symed Infratech Llp |
| Hari Babu Bodepudi DIN 01119687 | Director | 07 Jul 2021 | 5 yrs 3 mo | Symed Labs Limited |
| Kalidindi Srihari Raju DIN 00982034 | Director | 07 Jul 2021 | 5 yrs 3 mo | Symed Labs Limited |
| Vijayalakshmi Vaithianathan DIN 09228935 | Nominee Director | 07 Jul 2021 | 5 yrs 3 mo | Symed Labs Limited |
| Pradip Manilal Kanakia DIN 00770347 | Director | 04 Mar 2022 | 4 yrs 7 mo | Symed Labs Limited |
| Kamal Kishore Sharma DIN 00209430 | Director | 01 Dec 2022 | 3 yrs 10 mo | Symed Labs Limited |
| Srinivas Vasireddy DIN 09771153 | Director | 28 Jun 2023 | 3 yrs 4 mo | Symed Labs Limited |
| Anuj Vishnukumar Poddar DIN 01908009 | Director | 25 Jun 2025 | 1 yr 4 mo | Symed Labs Limited |
People of Symed
6 people are tracked at Symed (4 in leadership, 2 in team); the tracked headcount is 949.
| Name | Role | Group |
|---|---|---|
Parthasaradi Reddy | Co-Founder | Leadership |
| Co-Founder & Managing Director | Leadership | |
Gowtham Reddy .regalla | Assistant General Manager | Leadership |
Dr. D. Mohan Rao | Managing Director | Leadership |
Bharath Kumar | Safety Officer | Team |
Teja B | Supply Chain Manager (logistics ( | Team |
Complete people profiles for Symed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Symed
Figures of Symed Labs Limited, the primary company behind Symed, for FY 2025. Revenue was ₹792 Cr (+6% year on year). Net profit was ₹120 Cr (15% margin). EBITDA was ₹183 Cr (23% margin). Revenue has grown at a compounded annual rate of +17% over three years and +11% over five years.
- ₹792 CrRevenue · FY 2025 · +6% YoY
- ₹120 CrNet profit · 15% margin
- ₹183 CrEBITDA · 23% margin
- ₹93 LakhPaid-up capital
- 949Employees (provident fund records)
- +17%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Symed Labs Limited are on its company page.
Detailed financial statements for Symed
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Symed
2 dated milestones of Symed across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Symed is founded.
- Exit Acquired by Viyash.
Competitors of Symed
Symed has 3 listed competitors in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed competitors of Symed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Symed (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Symed
Complete news archive for Symed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Symed
Symed was founded in 1997.
Symed is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Symed has 949 employees.
The primary company behind Symed, Symed Labs Limited, reported revenue of ₹792 Cr for FY 2025, up 6% year on year.
Symed was founded in 1997 in Hyderabad, India, within the pharmaceutical sector. Active pharmaceutical ingredients are produced, alongside drug development services that support formulation and regulatory processes. Operations are centered in India, with a focus on API synthesis and custom development for global clients. Leadership includes co-founders Parthasaradi Reddy and Mohan Rao Dodda, who oversee manufacturing and strategic directions.
Symed's top competitors include Laurus Labs, Symbiotec and SeQuent.
Symed offers Active Pharmaceutical Ingredients and Contract Research Services.
Symed has 1 investor. Key investors include Viyash.
Symed is associated with 4 legal entities: Symed Labs Limited, Symed Infratech Llp, Unkeshwar Estates Llp and others.
Yes. Symed was acquired by Viyash in November 2021.
The legal entities of Symed currently have 11 directors, including Dodda Vandana, Spandana Dodda, Parthasaradhi Reddy Bandi and others.